AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
Hepatocellular carcinoma (HCC) poses a substantial health burden globally, with liver cancer being the fourth most common cause of cancer-related mortality worldwide. In China, where the incidence of ...
Mortality and 30-day readmissions among hepatocellular carcinoma patients hospitalized for portal vein thrombosis: A nationwide analysis. This is an ASCO Meeting Abstract from the 2026 ASCO ...
During the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago from Nov. 25 to 30, GE Healthcare announced the receipt of U.S. Food and Drug ...
Deciphering tumor microenvironment dynamics in HER2-amplified refractory metastatic colorectal cancer in the TRIUMPH trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results